An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease (AMARANTH)
I8D-MC-AZES - ClinicalTrials.gov - NCT02245737
Trial Summary
Age Range
55 - 85 yearsConditions the trial is for
What the trial is testing?
Lanabecestat (LY3314814)Could I receive a Placebo?
YesEnrollment Goal
2218Trial Dates
Sep 30, 2014 - Oct 4, 2018How long will I be in the trial?
Trial Phase
II / IIILilly Trial Alerts
Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.
You will complete the questionnaire on another website.YesNo